CD Diagnostics combines expertise in immunoassay development with biomarker research, patented technology, and cGMP manufacturing to deliver a range of products that address challenging diagnostic issues. We are improving patient outcomes by providing more accurate and rapid diagnosis. CD Diagnostics recently completed the acquisition of Citrano Medical Laboratories, a CLIA-certified laboratory that has provided comprehensive clinical testing services to clients for 39 years. Our CLIA laboratory and sample acquisition programs with major hospitals and medical research institutions facilitate the rapid development and commercialization of laboratory developed tests. Our first laboratory developed test for periprosthetic joint infection, Synovasure. LDT, was developed with Zimmer and released in November 2012. We are developing additional tests for other disease states and use as companion diagnostics.
August 2013CD Diagnostics Wins PACT Enterprise Award for Emerging Life Science Company Group Photo
November 4-6, 2013
November 8-10, 2013Dr. Deirmengian presents paper on biomarkers for Periprosthetic Joint Infection Saturday, November 9th at 4:21pm
December 11-14, 2013